팬젠 둜고

팬젠 (222110) μ£Όκ°€ 및 μ’…λͺ© 정보

팬젠 μ‹€μ‹œκ°„ μ£Όκ°€

팬젠 ν˜„μž¬κ°€ 상세 정보
ν•­λͺ© κ°’
ν˜„μž¬κ°€ 5,270 원
λ³€λ™λŸ‰ β–Ό 60.00 원
변동λ₯  -1.13%
κ±°λž˜λŸ‰ 9,197
κ±°λž˜λŒ€κΈˆ 48,176,520 원

팬젠 일별 μ£Όκ°€

팬젠의 κ³Όκ±° 일별 μ£Όκ°€
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
1/1/2026 5,570 5,600 5,430 5,530 9,157 50,288,950
1/4/2026 5,530 5,530 5,310 5,350 22,906 123,400,700
1/5/2026 5,350 5,430 5,220 5,360 16,308 86,492,920
1/6/2026 5,350 5,360 5,120 5,130 10,470 54,156,090
1/7/2026 5,130 5,230 5,090 5,200 7,486 38,530,660
1/8/2026 5,200 5,440 5,130 5,410 17,032 90,182,290
1/11/2026 5,370 5,440 5,190 5,320 10,682 56,402,410
1/12/2026 5,250 5,430 5,180 5,400 22,986 121,645,730
1/13/2026 5,420 5,420 5,220 5,330 7,561 40,045,070
1/14/2026 5,330 5,400 5,160 5,270 9,197 48,176,520

κ΄€λ ¨ ν…Œλ§ˆ

  • λ°”μ΄μ˜€μ‹œλ°€λŸ¬ : λ°”μ΄μ˜€μ‹œλ°€λŸ¬ μ˜μ•½ν’ˆ 개발, 제쑰 μ—…μ²΄λ‘œ λ°”μ΄μ˜€μ‹œλ°€λŸ¬ μ˜μ•½ν’ˆμ€ EPO(빈혈 치료제), Factor VIII(ν˜ˆμš°λ³‘A 치료제) 및 G-CSF(ν•­μ•”μΉ˜λ£Œ 보쑰제) μ œν’ˆμ„ 순차적으둜 개발 쀑
  • 혈μž₯치료 : ν˜ˆμš°λ³‘ μΉ˜λ£Œμ œμ™€ λ‹€μ–‘ν•œ ν˜ˆμ•‘ κ΄€λ ¨ 치료제λ₯Ό κ°œλ°œν•΄ 혈μž₯ 치료 관련주에 νŽΈμž…

팬젠 νšŒμ‚¬ 정보

μ‹œμž₯ μ‹œκ°€μ΄μ•‘ κΈ°μ—…μˆœμœ„ μ£Όμ‹μˆ˜ 외ꡭ인 비쀑 μ‚°μ—…κ΅° μ„ΈλΆ€ μ‚°μ—…κ΅° 52μ£Ό 졜고 52μ£Ό μ΅œμ €
kosdaq 711μ–΅ 1045μœ„ 13,494,197 7.41% ν—¬μŠ€μΌ€μ–΄ 생λͺ…κ³Όν•™/곡학 7,400 4,305

팬젠 κΈ°μ—… κ°œμš”

νŒ¬μ  μ€ 2010λ…„ 1μ›” μ„€λ¦½λœ κΈ°μ—…μœΌλ‘œ λ°”μ΄μ˜€μ‹œλ°€λŸ¬ EPO μ˜μ•½ν’ˆμ˜ 생산 및 판맀, λ°”μ΄μ˜€μ˜μ•½ν’ˆ 개발, λ°”μ΄μ˜€μ˜μ•½ν’ˆ μœ„νƒμƒμ‚° 및 개발기술 μ΄μ „μ„œλΉ„μŠ€ λ“±μ˜ 사업을 μ˜μœ„ν•˜κ³  μžˆλ‹€. μ£Όμš” λ§€μΆœμ€ EPO μ˜μ•½ν’ˆ νŒλ§€μ—μ„œ λ°œμƒν•˜κ³  μžˆλ‹€. λ‹Ήμ‚¬λŠ” λ§Œμ„± μ‹ λΆ€μ „ ν™˜μžμ˜ 빈혈 치료제인 λ°”μ΄μ˜€μ‹œλ°€λŸ¬ EPO μ˜μ•½ν’ˆ 자체 μ œν’ˆκ°œλ°œμ— μ„±κ³΅ν•˜μ—¬ κ΅­λ‚΄ 및 λ§λ ˆμ΄μ‹œμ•„ μ‹œμž₯μ—μ„œ 판맀 쀑에 있으며 κ·Έ 밖에 λ‹€μ–‘ν•œ λ°”μ΄μ˜€ μ˜μ•½ν’ˆμ„ 개발 쀑에 μžˆλ‹€.

팬젠 AI예츑

AIμ˜ˆμΈ‘κΈ°λŠ” νŒ¬μ  μ„ κ°•λ ₯맀도 Β· 맀도 Β· 쀑립 Β· 맀수 Β· κ°•λ ₯맀수 둜 μ˜ˆμΈ‘ν–ˆμ–΄μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ μ˜ˆμƒ μ£Όκ°€ μ‹œλ‚˜λ¦¬μ˜€μ™€ AI의 투자의견, λͺ©ν‘œΒ·μ†μ ˆκ°€, AIκ°€ μ°Έκ³ ν•œ 차트 νŒ¨ν„΄λ“€μ„ 확인할 수 μžˆμŠ΅λ‹ˆλ‹€.

팬젠 μ§€ν‘œλΆ„μ„

수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ€ νŒ¬μ  μ„ 맀수 Β· 맀도 Β· 보유 Β· 관망 μ€‘μ΄μ—μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ 수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ˜ 맀맀 μ‹œμ μ„ ν™•μΈν•˜κ³  λ‹€μŒ μ‹ ν˜Έλ₯Ό μ•Œλ¦ΌμœΌλ‘œ λ°›μ•„λ³Ό 수 μžˆμŠ΅λ‹ˆλ‹€.

μ΅œμ‹  팬젠 κ΄€λ ¨ λ‰΄μŠ€

νœ΄μ˜¨μŠ€κ·Έλ£Ήμ€ λ‚΄λ…„ 1μ›”1일자둜 νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œμ„ λΉ„λ‘―ν•œ κ³„μ—΄μ‚¬μ˜ μž„μ› 인사λ₯Ό λ‹¨ν–‰ν•œλ‹€κ³  24일 λ°ν˜”λ‹€. λ‹€μŒμ€ μŠΉμ§„μž λͺ…단이닀. β—†νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ ▷상무이사△ 이기세 β–³κΉ€μ •ν›ˆ ▷이사 β–³μ²œμ›νƒœ β–·μ΄μ‚¬λŒ€μš° β–³μ „λ―Όν˜Έ β–³μ΄ν˜Έκ΅­ β—†νœ΄μ˜¨μŠ€ ▷상무이사△ μŒν˜„μ•  β–³μ‘°μž¬λ―Ό β–³λ‚¨μŠΉκ΄€ ▷이사 β–³μ˜€μ„κ·  β–³λ‚¨μƒμš± β–³μ΅œμ’…ν›ˆ β–³λ°•ν˜œλ―Έ β–³ν™μ§€ν˜„ β–·μ΄μ‚¬λŒ€μš° △곡지원 △양지석 β–³μ΄μ§„μš° β–³μ œκ±΄ β—†νœ΄μ˜¨μŠ€μƒλͺ…κ³Όν•™ ▷상무이사 △김지홍 ▷이사 β–³κ°•κΆŒλ¬΅ β—†νœ΄λ©”λ”•μŠ€ ▷이사 △이기택 β–·μ΄μ‚¬λŒ€μš° β–³μ •λ―Όν˜• β–³κΉ€μƒν›ˆ β—†νœ΄μ˜¨μŠ€μ—” ▷이사 β–³μ •ν˜•μ²  β–³μœ€ν˜Έμ˜ β–·μ΄μ‚¬λŒ€μš° β–³μ†λ½ν˜Έ β–³ν™μ’…νƒœ...

νœ΄μ˜¨μŠ€κ·Έλ£Ήμ€ 2026λ…„ 1μ›” 1일자둜 νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œμ„ λΉ„λ‘―ν•œ κ³„μ—΄μ‚¬μ˜ μž„μ› 인사λ₯Ό λ‹¨ν–‰ν•œλ‹€κ³  24일 λ°ν˜”λ‹€.λ‹€μŒμ€ μŠΉμ§„μž λͺ…단이닀.β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ 이기세 β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ κΉ€μ •ν›ˆ β–²νœ΄μ˜¨μŠ€ μŒν˜„μ•  β–²νœ΄μ˜¨μŠ€ 쑰재민 β–²νœ΄μ˜¨μŠ€ λ‚¨μŠΉκ΄€ β–²νœ΄μ˜¨μŠ€μƒλͺ…κ³Όν•™ κΉ€μ§€ν™β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ μ²œμ›νƒœ β–²νœ΄μ˜¨μŠ€ μ˜€μ„κ·  β–²νœ΄μ˜¨μŠ€ λ‚¨μƒμš± β–²νœ΄μ˜¨μŠ€ μ΅œμ’…ν›ˆ β–²νœ΄μ˜¨μŠ€ λ°•ν˜œλ―Έ β–²νœ΄μ˜¨μŠ€ ν™μ§€ν˜„ β–²νœ΄λ©”λ”•μŠ€ 이기택 β–²νœ΄μ˜¨μŠ€μ—” μ •ν˜•μ²  β–²νœ΄μ˜¨μŠ€μ—” 윀호영 β–²νœ΄μ˜¨μŠ€μƒλͺ…κ³Όν•™ κ°•κΆŒλ¬΅β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ μ „λ―Όν˜Έ β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ 이호ꡭ β–²νœ΄μ˜¨μŠ€ 곡지원 β–²νœ΄μ˜¨μŠ€ 양지석 β–²νœ΄μ˜¨μŠ€ μ΄μ§„μš° β–²νœ΄μ˜¨μŠ€ 제건 β–²νœ΄λ©”λ”•μŠ€ μ •λ―Όν˜• β–²νœ΄λ©”λ”•μŠ€ κΉ€μƒν›ˆ β–²νœ΄μ˜¨μŠ€μ—” μ†λ½ν˜Έ β–²νœ΄μ˜¨μŠ€μ—” ν™μ’…νƒœ β–²νŒ¬μ   μ†‘ν˜„μ£Ό

β—‡ 상무이사 β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ 이기세 β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ κΉ€μ •ν›ˆ β–²νœ΄μ˜¨μŠ€ μŒν˜„μ•  β–²νœ΄μ˜¨μŠ€ 쑰재민 β–²νœ΄μ˜¨μŠ€ λ‚¨μŠΉκ΄€ β–²νœ΄μ˜¨μŠ€μƒλͺ…κ³Όν•™ 김지홍 β—‡ 이사 β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ μ²œμ›νƒœ β–²νœ΄μ˜¨μŠ€ μ˜€μ„κ·  β–²νœ΄μ˜¨μŠ€ λ‚¨μƒμš± β–²νœ΄μ˜¨μŠ€ μ΅œμ’…ν›ˆ β–²νœ΄μ˜¨μŠ€ λ°•ν˜œλ―Έ β–²νœ΄μ˜¨μŠ€ ν™μ§€ν˜„ β–²νœ΄λ©”λ”•μŠ€ 이기택 β–²νœ΄μ˜¨μŠ€μ—” μ •ν˜•μ²  β–²νœ΄μ˜¨μŠ€μ—” 윀호영 β–²νœ΄μ˜¨μŠ€μƒλͺ…κ³Όν•™ κ°•κΆŒλ¬΅ β—‡ μ΄μ‚¬λŒ€μš° β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ μ „λ―Όν˜Έ β–²νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ 이호ꡭ β–²νœ΄μ˜¨μŠ€ 곡지원

β—‡νœ΄μ˜¨μŠ€κ·Έλ£Ή <상무이사 μŠΉμ§„>β–³νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ 이기세 κΉ€μ •ν›ˆ β–³νœ΄μ˜¨μŠ€ μŒν˜„μ•  쑰재민 λ‚¨μŠΉκ΄€ β–³νœ΄μ˜¨μŠ€μƒλͺ…κ³Όν•™ 김지홍 <이사 μŠΉμ§„>β–³νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ μ²œμ›νƒœ β–³νœ΄μ˜¨μŠ€ μ˜€μ„κ·  λ‚¨μƒμš± μ΅œμ’…ν›ˆ λ°•ν˜œλ―Έ ν™μ§€ν˜„ β–³νœ΄λ©”λ”•μŠ€ 이기택 β–³νœ΄μ˜¨μŠ€μ—” μ •ν˜•μ²  윀호영 β–³νœ΄μ˜¨μŠ€μƒλͺ…κ³Όν•™ κ°•κΆŒλ¬΅ <μ΄μ‚¬λŒ€μš° 승

β—‡νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ μ΄κΈ°μ„Έβ—‡νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ κΉ€μ •ν›ˆβ—‡νœ΄μ˜¨μŠ€ μŒν˜„μ• β—‡νœ΄μ˜¨μŠ€ μ‘°μž¬λ―Όβ—‡νœ΄μ˜¨μŠ€ λ‚¨μŠΉκ΄€β—‡νœ΄μ˜¨μŠ€μƒλͺ…κ³Όν•™ 김지홍 β—‡νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ μ²œμ›νƒœ β—‡νœ΄μ˜¨μŠ€ μ˜€μ„κ·  β—‡νœ΄μ˜¨μŠ€ λ‚¨μƒμš± β—‡νœ΄μ˜¨μŠ€ μ΅œμ’…ν›ˆ β—‡νœ΄μ˜¨μŠ€ λ°•ν˜œλ―Έ β—‡νœ΄μ˜¨μŠ€ ν™μ§€ν˜„ β—‡νœ΄λ©”λ”•μŠ€ 이기택 β—‡νœ΄μ˜¨μŠ€μ—” μ •ν˜•μ²  β—‡νœ΄μ˜¨μŠ€μ—” 윀호영 β—‡νœ΄μ˜¨μŠ€μƒλͺ…κ³Όν•™ κ°•κΆŒλ¬΅ β—‡νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ μ „λ―Όν˜Έβ—‡νœ΄μ˜¨μŠ€κΈ€λ‘œλ²Œ μ΄ν˜Έκ΅­β—‡νœ΄μ˜¨μŠ€ κ³΅μ§€μ›β—‡νœ΄μ˜¨μŠ€ μ–‘μ§€μ„β—‡νœ΄μ˜¨μŠ€ μ΄μ§„μš°β—‡νœ΄μ˜¨μŠ€ μ œκ±΄β—‡νœ΄λ©”λ”•μŠ€ μ •λ―Όν˜•β—‡νœ΄λ©”λ”•μŠ€ κΉ€μƒν›ˆβ—‡νœ΄μ˜¨μŠ€μ—” μ†λ½ν˜Έβ—‡νœ΄μ˜¨μŠ€μ—” ν™μ’…νƒœβ—‡νŒ¬μ   μ†‘ν˜„μ£Ό

팬젠 맀좜 정보

λ‚ μ§œ λ§€μΆœμ•‘ λ§€μΆœμ•‘ μ¦κ°€μœ¨ μ˜μ—…μ΄μ΅ μ˜μ—…μ΄μ΅ μ¦κ°€μœ¨ 순이읡 순이읡 μ¦κ°€μœ¨
2024.4Q 14,672,686,810 - 1,020,165,959 - 943,686,868 -
2023.4Q 7,315,125,370 12.53% -4,225,497,054 7.95% -4,488,830,770 0.11%
2022.4Q 6,500,658,000 -18.08% -4,590,629,400 -39.60% -4,493,832,000 -35.75%
2021.4Q 7,935,565,000 28.18% -3,288,356,900 11.13% -3,310,318,300 24.01%

μˆœλ§€μˆ˜λŸ‰

개인: -747

κΈ°κ΄€: 0

외인: 559

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: -105,463

κΈ°κ΄€: -42,087

외인: 122,988

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-01-15 -747 - 559
2026-01-14 1,870 - -1,870
2026-01-13 -2,740 - 2,740
2026-01-12 -1,439 - 1,439
2026-01-09 -4,922 - 5,431
2026-01-08 686 - -849
2026-01-07 -1,658 - 1,063
2026-01-06 115 - 52
2026-01-05 2,492 - -3,066
2026-01-02 -1,516 - 1,272
2025-12-30 106 - -280
2025-12-29 -2,295 - 2,647
2025-12-26 -4,602 - 4,419
2025-12-24 -5,273 - 5,104
2025-12-23 -3,560 - 3,560
2025-12-22 -1,465 - 1,465
2025-12-19 -3,156 - 2,239
2025-12-18 -1,010 - 1,011
2025-12-17 -6,068 - 5,984
2025-12-16 -12,320 - 12,679
2025-12-15 -1,425 - 1,066

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-01-15 -48,927 - 46,665
2026-01-14 -48,180 - 46,106
2026-01-13 -50,050 - 47,976
2026-01-12 -47,310 - 45,236
2026-01-09 -45,871 - 43,797
2026-01-08 -40,949 - 38,366
2026-01-07 -41,635 - 39,215
2026-01-06 -39,977 - 38,152
2026-01-05 -40,092 - 38,100
2026-01-02 -42,584 - 41,166
2025-12-30 -41,068 - 39,894
2025-12-29 -41,174 - 40,174
2025-12-26 -38,879 - 37,527
2025-12-24 -34,277 - 33,108
2025-12-23 -29,004 - 28,004
2025-12-22 -25,444 - 24,444
2025-12-19 -23,979 - 22,979
2025-12-18 -20,823 - 20,740
2025-12-17 -19,813 - 19,729
2025-12-16 -13,745 - 13,745
2025-12-15 -1,425 - 1,066

팬젠 μžμ‚° λΉ„μœ¨

μžμ‚°μ΄κ³„ λΆ€μ±„λΉ„μœ¨ μžλ³ΈλΉ„μœ¨
32,764,984,316 8.36% 91.64%

팬젠 맀좜 ꡬ성

ꡬ성 μš”μ†Œ λΉ„μœ¨
λ°”μ΄μ˜€μ‹œλ°€λŸ¬ EPO [EPOμ˜μ•½ν’ˆ] 46.6%
μœ„νƒμƒμ‚°(CMO) 21.8%
기타 13.3%
κΈ°μˆ μ΄μ „(CDO) 13.2%
λ‘œμ—΄ν‹° 3.7%
μƒν’ˆ 1.4%

팬젠 곡맀도 ν˜„ν™©

졜근 곡맀도 κ±°λž˜λŸ‰: 1,555 (16.91%)

졜근 곡맀도 μž”κ³ : 42,087 (0.31%)

곡맀도 κ±°λž˜λŸ‰

λ‚ μ§œ μ’…κ°€ κ³΅λ§€λ„λŸ‰ 곡맀도비쀑
2026-01-15 5,270 1,555 16.91%
2026-01-14 5,330 1,397 18.48%
2026-01-13 5,400 2,841 12.36%
2026-01-12 5,320 1,198 11.22%
2026-01-09 5,410 41 0.24%
2026-01-08 5,200 0 0.00%
2026-01-07 5,130 82 0.78%
2026-01-06 5,360 8 0.05%
2026-01-05 5,350 0 0.00%
2026-01-02 5,530 38 0.41%
2025-12-30 5,600 23 0.29%
2025-12-29 5,730 110 0.58%
2025-12-26 5,650 65 0.48%
2025-12-24 5,790 104 0.44%
2025-12-23 5,850 210 2.42%
2025-12-22 5,890 0 0.00%
2025-12-19 5,890 44 0.57%
2025-12-18 5,870 1 0.04%
2025-12-17 5,870 16 0.11%
2025-12-16 5,850 38 0.22%
2025-12-15 5,780 79 0.58%

곡맀도 μž”κ³ 

λ‚ μ§œ μ’…κ°€ 곡맀도 μž”κ³  곡맀도 비쀑
2026-01-13 5,400 42,087 0.31%
2026-01-12 5,320 42,087 0.31%
2026-01-09 5,410 42,087 0.31%
2026-01-08 5,200 42,087 0.31%
2026-01-07 5,130 42,087 0.31%
2026-01-06 5,360 42,087 0.31%
2026-01-05 5,350 42,087 0.31%
2026-01-02 5,530 42,087 0.31%
2025-12-30 5,600 42,087 0.31%
2025-12-29 5,730 42,087 0.31%
2025-12-26 5,650 42,087 0.31%
2025-12-24 5,790 42,087 0.31%
2025-12-23 5,850 42,087 0.31%
2025-12-22 5,890 42,087 0.31%
2025-12-19 5,890 42,087 0.31%
2025-12-18 5,870 42,087 0.31%
2025-12-17 5,870 42,087 0.31%
2025-12-16 5,850 42,087 0.31%
2025-12-15 5,780 42,087 0.31%
2025-12-12 5,960 42,087 0.31%
2025-12-11 5,970 42,087 0.31%

팬젠 μ—…μ’… λ‚΄ 비ꡐ

생λͺ…κ³Όν•™/곡학 μ—…μ’…(90개) μ—°κ°„ κΈ°μ€€

ν•­λͺ© 팬젠 μ—…μ’… 평균 μ—…μ’… λ‚΄ μˆœμœ„
μ‹œκ°€μ΄μ•‘ 719.241 10,669.81 69μœ„
PER(졜근4λΆ„κΈ°) 41.784 -151.65 6μœ„
PBR 2.395 25.4 59μœ„
ROE(졜근4λΆ„κΈ°) - - -μœ„
λ°°λ‹Ήμˆ˜μ΅λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
μ˜μ—…μ΄μ΅λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
순이읡λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
λΆ€μ±„λΉ„μœ¨(μ΅œκ·Όμ—°λ„) - - -μœ„
λ§€μΆœμ•‘(μ΅œκ·Όμ—°λ„) 146.727 491.13 33μœ„
μ˜μ—…μ΄μ΅(μ΅œκ·Όμ—°λ„) 10.202 -88.96 16μœ„
λ‹ΉκΈ°μˆœμ΄μ΅(μ΅œκ·Όμ—°λ„) 9.437 -66.78 24μœ„